AIC
AXDX

Ameritas Investment Company’s Accelerate Diagnostics AXDX Stock Holding History

Ameritas Investment Company’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-100
Closed -$12K – 1028
2018
Q4 		$12K Buy
+100
New +$14.8K ﹤0.01% 989

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Ameritas Investment Company's AXDX Position: Q1 2019 in Review

Ameritas Investment Company sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 100 shares — an estimated $12K sold.

Ameritas Investment Company first reported a position in AXDX in Q4 2018 and held it in 1 quarter. The position peaked at $12K in Q4 2018. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

  • Ameritas Investment Company reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
  • Ameritas Investment Company sold 100 Accelerate Diagnostics shares in Q1 2019, an estimated $12K.
  • Ameritas Investment Company first reported a position in Accelerate Diagnostics in Q4 2018 and held it in 1 quarter.
  • Ameritas Investment Company's Accelerate Diagnostics position peaked at $12K in Q4 2018.
  • 114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Ameritas Investment Company's 13F filing for Q1 2019, filed 16 May 2019.